Alpha Mark Advisors, LLC Bristol Myers Squibb CO Transaction History

Alpha Mark Advisors, LLC

$231 Million
Q4 2024

A detailed history of Alpha Mark Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Alpha Mark Advisors, LLC holds 40,089 shares of BMY stock, worth $2.36 Million. This represents 0.98% of its overall portfolio holdings.

Number of Shares

40,089

Previous 40,974 2.16%

Holding current value

$2.36 Million

Previous $2.12 Million 6.93%

% of portfolio

0.98%

Previous 0.73%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 21, 2025	SELL	$51.92 - $59.94 $45,949 - $53,046	-885 Reduced 2.16%	40,089 $2.27 Million
Q3 2024 Oct 16, 2024	BUY	$39.66 - $51.75 $67,739 - $88,389	1,708 Added 4.35%	40,974 $2.12 Million
Q2 2024 Jul 17, 2024	BUY	$40.25 - $52.99 $670,605 - $882,866	16,661 Added 73.7%	39,266 $1.63 Million
Q1 2024 Apr 18, 2024	BUY	$47.98 - $54.4 $24,661 - $27,961	514 Added 2.33%	22,605 $1.23 Million
Q4 2023 Jan 19, 2024	SELL	$48.48 - $57.85 $52,794 - $62,998	-1,089 Reduced 4.7%	22,091 $1.13 Million
Q3 2023 Oct 31, 2023	BUY	$57.89 - $64.73 $30,102 - $33,659	520 Added 2.29%	23,180 $1.35 Million
Q2 2023 Jul 28, 2023	SELL	$63.71 - $70.74 $164,817 - $183,004	-2,587 Reduced 10.25%	22,660 $1.45 Million
Q1 2023 May 04, 2023	BUY	$65.71 - $74.53 $4,796 - $5,440	73 Added 0.29%	25,247 $1.75 Million
Q4 2022 Feb 06, 2023	BUY	$68.48 - $81.09 $1,575 - $1,865	23 Added 0.09%	25,174 $1.81 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $51 - $30,505	397 Added 1.6%	25,151 $1.79 Million
Q2 2022 Aug 11, 2022	BUY	$72.62 - $79.98 $4,357 - $4,798	60 Added 0.24%	24,754 $1.91 Million
Q1 2022 May 02, 2022	SELL	$61.48 - $73.72 $7,746 - $9,288	-126 Reduced 0.51%	24,694 $1.8 Million
Q4 2021 Feb 09, 2022	SELL	$53.63 - $62.52 $44,298 - $51,641	-826 Reduced 3.22%	24,820 $1.55 Million
Q3 2021 Nov 05, 2021	BUY	$59.17 - $69.31 $14,496 - $16,980	245 Added 0.96%	25,646 $1.52 Million
Q2 2021 Aug 06, 2021	BUY	$61.91 - $67.42 $8,357 - $9,101	135 Added 0.53%	25,401 $1.7 Million
Q1 2021 Apr 29, 2021	SELL	$59.34 - $66.74 $157,310 - $176,927	-2,651 Reduced 9.5%	25,266 $1.6 Million
Q4 2020 Feb 01, 2021	SELL	$57.74 - $65.43 $1.08 Million - $1.23 Million	-18,777 Reduced 40.21%	27,917 $1.73 Million
Q3 2020 Nov 06, 2020	BUY	$57.43 - $63.64 $174,472 - $193,338	3,038 Added 6.96%	46,694 $2.82 Million
Q2 2020 Aug 10, 2020	BUY	$54.82 - $64.09 $17,268 - $20,188	315 Added 0.73%	43,656 $2.57 Million
Q1 2020 Apr 24, 2020	SELL	$46.4 - $67.43 $13,827 - $20,094	-298 Reduced 0.68%	43,341 $2.42 Million
Q4 2019 Feb 07, 2020	BUY	$49.21 - $64.19 $2.14 Million - $2.79 Million	43,389 Added 17355.6%	43,639 $2.8 Million
Q3 2018 Nov 05, 2018	SELL	$55.19 - $62.25 $16,557 - $18,675	-300 Reduced 54.55%	250 $16,000
Q2 2018 Aug 03, 2018	SELL	$50.53 - $62.98 $12,632 - $15,745	-250 Reduced 31.25%	550 $30,000
Q4 2017 Feb 09, 2018	SELL	$59.94 - $65.35 $5,994 - $6,534	-100 Reduced 11.11%	800 $49,000
Q3 2017 Nov 02, 2017	BUY	$55.23 - $63.74 $49,707 - $57,366	900	900 $57,000

Others Institutions Holding BMY

# of Institutions

2,602

Shares Held

1.46B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Mark Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Mark Advisors, LLC with notifications on news.

Account

Alpha Mark Advisors, LLC Bristol Myers Squibb CO Transaction History